Evidence map›Paper›PMID 34761157›Full record

ArticleResearch and practice in thrombosis and haemostasis2021

Interlaboratory variability of activated protein C resistance using the ETP-based APC resistance assay.

Laure Morimont, Marie Didembourg, Hélène Haguet, Élise Modaffari, Maxence Tillier, Céline Bouvy, Aurélien Lebreton, Jean-Michel Dogné, Jonathan Douxfils

Open access · goldAbstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Chapter 3. Impact of estrogens on hemostasis.Frontiers in endocrinology · 2025
    Review
  2. Evaluation of Activated Protein C Resistance Using Thrombin Generation Test.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Laure MorimontQualiblood sa Namur Belgium.ORCID https://orcid.org/0000-0001-9195-304X
Marie DidembourgFaculty of Medicine Department of Pharmacy Namur Research Institute for Life Sciences (NARILIS) Namur Thrombosis and Hemostasis Center (NTHC) University of Namur Namur Belgium.
Hélène HaguetQualiblood sa Namur Belgium.
Élise ModaffariQualiblood sa Namur Belgium.
Maxence TillierService d'hématologie Biologique CHU Clermont-Ferrand Clermont-Ferrand France.
Céline BouvyQualiblood sa Namur Belgium.
Aurélien LebretonService d'hématologie Biologique CHU Clermont-Ferrand Clermont-Ferrand France.ORCID https://orcid.org/0000-0002-1650-0427
Jean-Michel DognéFaculty of Medicine Department of Pharmacy Namur Research Institute for Life Sciences (NARILIS) Namur Thrombosis and Hemostasis Center (NTHC) University of Namur Namur Belgium.
Jonathan DouxfilsQualiblood sa Namur Belgium.ORCID https://orcid.org/0000-0002-7644-5298
University of Namur · BECentre Hospitalier Universitaire de Clermont-Ferrand · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveAlthough the endogenous thrombin potential (ETP)-based activated protein C (APC) resistance is recommended for the development of steroid contraceptive agents, one of the main limitations of this technique was its lack of standardization, which hampered study-to-study comparison. A validated methodology that meets all the regulatory requirements in terms of analytical performances has been developed recently. To ensure a wide implementation of this test, the assessment of the interlaboratory variability was needed.

methodThe assay was implemented in three testing laboratories. First, dose-response curves were performed to locally define APC concentration leading to 90% of ETP inhibition on healthy donors. Intra- and inter-run repeatability were assessed on a reference plasma and three quality controls. To investigate the variability in results among the different testing units, 60 donor samples were analyzed at each site.

resultsThe APC concentration leading to 90% of ETP inhibition was defined at 1.21 µg/ml and 1.14 µg/ml in the two receiving units. Intra- and inter-run repeatability showed standard deviation below 3%. Analyses of the 60 donor samples showed no statistically significant difference. The sensitivity of the test in the different laboratories was maintained and subgroup analyses still reported significant differences depending on hormonal status of donors.

conclusionThis study is the first reporting the interlaboratory variability of the ETP-based APC resistance assay. Data revealed excellent intra- and interlaboratory reproducibility. These results support the concept that this blood coagulation test provides an appropriate sensitivity irrespective of the laboratory in which analyses are performed.

Indexed as

activated protein C resistanceblood coagulation testcontraceptive agentslaboratoriesreproducibility of results

Identifiers

PMID34761157
PMCPMC8563922
OpenAlexW3210956841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.